WATERS CORP /DE/
HighWAT · NYSE · Laboratory Analytical Instruments · CIK 0001000697
Latest filing: 10-K · 2026-02-23
Customer concentration
Significant Customers note · revenue dependency
Top exposure
59%
Pharmaceutical Customers
| Individual Customers | 2% |
Members of this group
+1.0pp YoY
Click a point to open the SEC source
Geographic concentration
Segment reporting · geographic revenue
Top exposure
36.7%
Americas Other
-1.0pp YoY
Click a point to open the SEC source
Supplier concentration
Risk Factors · supply chain dependency
Dependency
Single source
Single sourceNamed
Qualitative disclosure — no % quantified (informational, not scored)
Flat
FY25
Qualitative dependency level by filing year.
Product concentration
ASC 275 · disclosed dependence on a specific product or service
Top exposure
≥35%
servicing and support of instruments
The filing discloses a minimum threshold — at least 35%; the exact figure is not quantified.
Products disclosed
| servicing and support of instruments | ≥35% |
| servicing and support of TA's instruments | ≥25% |
Flat
Click a point to open the SEC source
Credit concentration
ASC 825 · concentration of credit risk note
Receivables
<10%
Diversified
Flat
